Biosimilars: Extrapolating the evidence. A roundtable discussion
Main Authors: | Bradley J. Monk, Morton Coleman, Philip Lammers, George Somlo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | EJC Supplements |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1359634916000021 |
Similar Items
-
Biosimilars and the extrapolation of indications for inflammatory conditions
by: Tesser JRP, et al.
Published: (2017-02-01) -
Roundtable Audio Discussion
by: Chris Bigum, et al.
Published: (2007-01-01) -
Roundtable Discussion Leader
by: Caey, Laura, et al.
Published: (2017) -
Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
by: Markus A.C. Gifoni, et al.
Published: (2017-05-01) -
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey
by: Monk, Bradley, et al.
Published: (2017)